24 year outcomes of hepatitis B vaccination in Hangzhou, China

References

• Immunisation against infectious disease–1996 Edward Jenner Bicentenary Edition. Commun Dis Rep CDR Wkly 1996; 6(39):339; PMID:8897732
   PubMedGoogle Scholar
• Aspinall EJ, Hawkins G, Fraser A, Hutchinson SJ, Goldberg D. Hepatitis B prevention, diagnosis, treatment and care: a review. Occup Med (Lond) 2011; 61(8):531-40; PMID:22114089; http://dx.doi.org/10.1093/occmed/kqr136
   PubMed Web of Science ®Google Scholar
• Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45(4):529-38; PMID:16879891; http://dx.doi.org/10.1016/j.jhep.2006.05.013
   PubMed Web of Science ®Google Scholar
• Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 2002; 11(4):369-76; PMID:11927497
   PubMed Web of Science ®Google Scholar
• Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005; 34(6):1329-39; PMID:16249217; http://dx.doi.org/10.1093/ije/dyi206
   PubMed Web of Science ®Google Scholar
• Bozorgi SH, Ramezani H, Nooranipour M, Ahmadi M, Baghernejad A, Mostajeri A, Kargar-Fard H, Sadri M, Alavian SM. Risk factors of viral hepatitis: yet to explore. Transfus Apher Sci 2012; 47(2):145-9; PMID:22858443; http://dx.doi.org/10.1016/j.transci.2012.06.023
   PubMed Web of Science ®Google Scholar
• Vitaliti G, Pratico AD, Cimino C, Di Dio G, Lionetti E, La Rosa M, Leonardi S. Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow. World J Gastroenterol 2013; 19(6):838-45; PMID:23430309; http://dx.doi.org/10.3748/wjg.v19.i6.838
   PubMed Web of Science ®Google Scholar
• Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 1993; 262(5132):369-70; PMID:8211155; http://dx.doi.org/10.1126/science.8211155
   PubMed Web of Science ®Google Scholar
• de Franchis R, Hadengue A, Lau G, Lavanchy D, Lok A, McIntyre N, Mele A, Paumgartner G, Pietrangelo A, Rodés J, et al. EASL international consensus conference on hepatitis B. 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol 2003; 39 Suppl 1:S3-25; PMID:14708673
   PubMedGoogle Scholar
• Ganem D, Prince AM. Hepatitis B virus infection–natural history and clinical consequences. N Engl J Med 2004; 350(11):1118-29; PMID:15014185; http://dx.doi.org/10.1056/NEJMra031087
   PubMed Web of Science ®Google Scholar
• He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen CS, Chen J, Wildman RP, et al. Major causes of death among men and women in China. N Engl J Med 2005; 353(11):1124-34; PMID:16162883; http://dx.doi.org/10.1056/NEJMsa050467
   PubMed Web of Science ®Google Scholar
• Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004; 38(10 Suppl 3):S158-68; PMID:15602165
   PubMed Web of Science ®Google Scholar
• Muthuphei MN. Childhood liver diseases in ga-rankuwa hospital, South Africa. East Afr Med J 2000; 77(9):508-9; PMID:12862144
   PubMed Web of Science ®Google Scholar
• Huy TT, Abe K. Molecular epidemiology of hepatitis B and C virus infections in Asia. Pediatr Int 2004; 46(2):223-30; PMID:15056256; http://dx.doi.org/10.1046/j.1442-200x.2004.01867.x
   PubMed Web of Science ®Google Scholar
• Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11(2):97-107; PMID:14996343; http://dx.doi.org/10.1046/j.1365-2893.2003.00487.x
   PubMed Web of Science ®Google Scholar
• Kohn MA, Farley TA, Scott C. The need for more aggressive follow-up of children born to hepatitis B surface antigen-positive mothers: lessons from the Louisiana Perinatal Hepatitis B Immunization Program. Pediatr Infect Dis J 1996; 15(6):535-40.
   PubMed Web of Science ®Google Scholar
• Baytan B, Gunes AM, Gunay U. Efficacy of primary hepatitis B immunization in children with acute lymphoblastic leukemia. Indian Pediatr 2008; 45(4):265-70; PMID:18451443
   PubMed Web of Science ®Google Scholar
• Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997; 336(26):1855-9; PMID:9197213; http://dx.doi.org/10.1056/NEJM199706263362602
   PubMed Web of Science ®Google Scholar
• Lin HH, Wang LY, Hu CT, Huang SC, Huang LC, Lin SS, Chiang YM, Liu TT, Chen CL. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol 2003; 69(4):471-4; PMID:12601753; http://dx.doi.org/10.1002/jmv.10333
   PubMed Web of Science ®Google Scholar
• Poland GA, Jacobson RM. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 2004; 351(27):2832-8; PMID:15625334; http://dx.doi.org/10.1056/NEJMcp041507
   PubMed Web of Science ®Google Scholar
• Goldstein ST, Alter MJ, Williams IT, Moyer LA, Judson FN, Mottram K, Fleenor M, Ryder PL, Margolis HS. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis 2002; 185(6):713-9; PMID:11920288; http://dx.doi.org/10.1086/339192
   PubMed Web of Science ®Google Scholar
• Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 2006; 332(7537):328-36; PMID:16443611; http://dx.doi.org/10.1136/bmj.38719.435833.7C
   PubMed Web of Science ®Google Scholar
• Van Herck K, Van Damme P. Benefits of early hepatitis B immunization programs for newborns and infants. Pediatr Infect Dis J 2008; 27(10):861-9; PMID:18776823; http://dx.doi.org/10.1097/INF.0b013e318173966f
   PubMed Web of Science ®Google Scholar
• Chang MH. Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization. Liver Int 2003; 23(5):309-14; PMID:14708890; http://dx.doi.org/10.1034/j.1478-3231.2003.00865.x
   PubMed Web of Science ®Google Scholar
• Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet 2003; 362(9401):2089-94; PMID:14697813; http://dx.doi.org/10.1016/S0140-6736(03)15108-2
   PubMed Web of Science ®Google Scholar
• Beasley RP. Development of hepatitis B vaccine. JAMA 2009; 302(3):322-4; http://dx.doi.org/10.1001/jama.2009.1024
   PubMed Web of Science ®Google Scholar
• Global progress toward universal childhood hepatitis B vaccination, 2003. MMWR Morb Mortal Wkly Rep 2003; 52(36):868-870; PMID:12970620
   PubMedGoogle Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 2009; 200(1):39-47; PMID:19469708; http://dx.doi.org/10.1086/599332
   PubMed Web of Science ®Google Scholar
• Zhou YH, Wu C, Zhuang H. Vaccination against hepatitis B: the Chinese experience. Chin Med J (Engl) 2009; 122(1):98-102; PMID:19187625
   PubMed Web of Science ®Google Scholar
• Lu FM, Zhuang H. Prevention of hepatitis B in China: achievements and challenges. Chin Med J (Engl) 2009; 122(24):2925-7; PMID:20137475
   PubMed Web of Science ®Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27(47):6550-7; PMID:19729084; http://dx.doi.org/10.1016/j.vaccine.2009.08.048
   PubMed Web of Science ®Google Scholar
• Progress in hepatitis B prevention through universal infant vaccination–China, 1997-2006. MMWR Morb Mortal Wkly Rep 2007; 56(18):441-5; PMID:17495790
   PubMedGoogle Scholar
• Andersson A, Qvarfordt I, Laan M, Sjostrand M, Malmhall C, Riise GC, Cardell LO, Linden A. Impact of tobacco smoke on interleukin-16 protein in human airways, lymphoid tissue and T lymphocytes. Clin Exp Immunol 2004; 138(1):75-82; PMID:15373908; http://dx.doi.org/10.1111/j.1365-2249.2004.02580.x
   PubMed Web of Science ®Google Scholar
• Shen LP, Zhang Y, Wang F, Zhang S, Yang JY, Fang KX, Yu T, Wang XY, Zhang WY, Bi SL. Epidemiological changes in hepatitis B prevalence in an entire population after 20 years of the universal HBV vaccination programme. Epidemiol Infect 2011; 139(8):1159-65; PMID:21156099; http://dx.doi.org/10.1017/S0950268810002827
   PubMed Web of Science ®Google Scholar
• Xia G.L., Li C.B., Cao H.L., et al. Prevalence of hepatitis B and C virus infections in the conventional Chinese population: results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D and E virus infections in China, 1992. Int Hepatol Commun (1996) 5:12.
   Web of Science ®Google Scholar
• Puro V, De Carli G, Cicalini S, Soldani F, Balslev U, Begovac J, Boaventura L, Campins Martí M, Hernández Navarrete MJ, Kammerlander R, et al. European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus. Euro Surveill 2005; 10(10):260-4; PMID:16282641
   PubMedGoogle Scholar
• Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, Kao JH, Lin YC, Chen HL, Hsu HY, et al. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. Gastroenterology 2007; 132(4):1287-93; PMID:17433322; http://dx.doi.org/10.1053/j.gastro.2007.02.055
   PubMed Web of Science ®Google Scholar
• Mele A, Tancredi F, Romano L, Giuseppone A, Colucci M, Sangiuolo A, Lecce R, Adamo B, Tosti ME, Taliani G, et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis 2001; 184(7):905-8; http://dx.doi.org/10.1086/323396
   PubMed Web of Science ®Google Scholar
• Wu JS, Hwang LY, Goodman KJ, Beasley RP. Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis 1999; 179(6):1319-25; PMID:10228050; http://dx.doi.org/10.1086/314768
   PubMed Web of Science ®Google Scholar
• Huang LM, Chiang BL, Lee CY, Lee PI, Chi WK, Chang MH. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen. Hepatology 1999; 29(3):954-9; PMID:10051503; http://dx.doi.org/10.1002/hep.510290349
   PubMed Web of Science ®Google Scholar
• Liao SS, Li RC, Li H, Yang JY, Zeng XJ, Gong J, Wang SS, Li YP, Zhang KL. Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children. Vaccine 1999; 17(20-21):2661-6; PMID:10418916; http://dx.doi.org/10.1016/S0264-410X(99)00031-6
   PubMed Web of Science ®Google Scholar
• Whittle H, Jaffar S, Wansbrough M, Mendy M, Dumpis U, Collinson A, Hall A. Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. BMJ 2002; 325(7364):569; PMID:12228132; http://dx.doi.org/10.1136/bmj.325.7364.569
   PubMed Web of Science ®Google Scholar
• Coursaget P, Leboulleux D, Soumare M, le Cann P, Yvonnet B, Chiron JP, Coll-Seck AM, Diop-Mar I. Twelve-year follow-up study of hepatitis B immunization of Senegalese infants. J Hepatol 1994; 21(2):250-4; PMID:7989718; http://dx.doi.org/10.1016/S0168-8278(05)80404-0
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, Khristova M, Zanis C, Peters H, Margolis HS. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 2005; 142(5):333-41; PMID:15738452; http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00008
   PubMed Web of Science ®Google Scholar
• Acute hepatitis B among children and adolescents–United States, 1990-2002. MMWR Morb Mortal Wkly Rep 2004; 53(43):1015-1018; PMID:15525899
   PubMedGoogle Scholar
• Liu C, Li H, Gao L, Li F, Liang X, Yang K. Hepatitis B immunisation leads to the decline of hepatitis B virus prevalence in Gansu province, China. Aust N Z J Public Health 2011; 35(1):91-2; PMID:21299712; http://dx.doi.org/10.1111/j.1753-6405.2010.00670.x
   PubMed Web of Science ®Google Scholar
• Zhang L, Xu A, Yan B, Song L, Li M, Xiao Z, Xu Q, Li L. A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination. Int J Infect Dis 2010; 14(6):e483-488; PMID:19939719; http://dx.doi.org/10.1016/j.ijid.2009.08.005
   PubMed Web of Science ®Google Scholar
• Cacciola I, Cerenzia G, Pollicino T, Squadrito G, Castellaneta S, Zanetti AR, Mieli-Vergani G, Raimondo G. Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. J Hepatol 2002; 36(3):426-32; PMID:11867188; http://dx.doi.org/10.1016/S0168-8278(01)00295-1
   PubMed Web of Science ®Google Scholar
• Papadakis MA, Elefsiniotis IS, Vlahos G, Daskalakis G, Barbatis C, Antsaklis A. Intrauterine-transplacental transmission of hepatitis B virus (HBV) from hepatitis B e antigen negative (precore mutant, G1896A) chronic HBV infected mothers to their infants. Preliminary results of a prospective study. J Clin Virol 2007; 38(2):181-3; PMID:17142098; http://dx.doi.org/10.1016/j.jcv.2006.10.008
   PubMed Web of Science ®Google Scholar
• Zhang SL, Yue YF, Bai GQ, Shi L, Jiang H. Mechanism of intrauterine infection of hepatitis B virus. World J Gastroenterol 2004; 10(3):437-8; PMID:14760774
   PubMed Web of Science ®Google Scholar
• Ding Y, Sheng QJ, Ma L, Dou X. Chronic HBV infection among pregnant women and their infants in Shenyang, China. Virology Journal, 2013, 10(1):17; PMID:23294983
   PubMedGoogle Scholar
• Garland SM, Skinner SR, Brotherton JM. Adolescent and young adult HPV vaccination in Australia: achievements and challenges. Prev Med 2011; 53 Suppl 1:S29-35; PMID:21962468
   PubMed Web of Science ®Google Scholar
• Kim TH, Johnstone J, Loeb M. Vaccine herd effect. Scand J Infect Dis 2011; 43(9):683-9; PMID:21604922
   PubMed Web of Science ®Google Scholar
• Trotter CL, Maiden MC. Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Rev Vaccines 2009; 8(7):851-61; PMID:19538112; http://dx.doi.org/10.1586/erv.09.48
   PubMed Web of Science ®Google Scholar
• van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003; 10(4):294-7; PMID:12823596; http://dx.doi.org/10.1046/j.1365-2893.2003.00440.x
   PubMed Web of Science ®Google Scholar
• Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, Zhang SL, Qiao FY, Campbell F, Chang CN, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009; 16(2):94-103; http://dx.doi.org/10.1111/j.1365-2893.2008.01056.x
   PubMed Web of Science ®Google Scholar
• Han GR, Cao MK, Zhao W, Jiang HX, Wang CM, Bai SF, Yue X, Wang GJ, Tang X, Fang ZX. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 2011; 55(6):1215-21; http://dx.doi.org/10.1016/j.jhep.2011.02.032
   PubMed Web of Science ®Google Scholar
• Duval B, Boulianne N, De Serres G, Laflamme N, De Wals P, Massé R, Trudeau G, Delage G, Desjardins L. Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10-year-old children. Vaccine 2000; 18(15):1467-72; PMID:10618544; http://dx.doi.org/10.1016/S0264-410X(99)00422-3
   PubMed Web of Science ®Google Scholar
• Goh KT, Tan KL, Kong KH, Oon CJ, Chan SH. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study. Bull World Health Organ 1992; 70(2):233-9; PMID:1600584
   PubMed Web of Science ®Google Scholar
• Chiaramonte M, Majori S, Ngatchu T, Moschen ME, Baldo V, Renzulli G, Simoncello I, Rocco S, Bertin T, Naccarato R, et al. Two different dosages of yeast derived recombinant hepatitis B vaccines: a comparison of immunogenicity. Vaccine 1996; 14(2):135-7; PMID:8852410; http://dx.doi.org/10.1016/0264-410X(95)00148-T
   PubMed Web of Science ®Google Scholar
• ul-Haq N, Hasnain SS, Umar M, Abbas Z, Valenzuela-Silva C, Lopez-Saura P. Immunogenicity of 10 and 20 microgram hepatitis B vaccine in a two-dose schedule. Vaccine 2003; 21(23):3179-85; PMID:12804846; http://dx.doi.org/10.1016/S0264-410X(03)00232-9
   PubMed Web of Science ®Google Scholar
• Schiff GM, Sherwood JR, Zeldis JB, Krause DS. Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents. J Adolesc Health 1995; 16(1):12-7; PMID:7742331; http://dx.doi.org/10.1016/1054-139X(94)00105-N
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhuang GH, Wang XL, Hou TJ, Shah DP, Wei XL, Wang LR, Zhang M. Comparison of long-term immunogenicity (23 years) of 10 mug and 20 mug doses of hepatitis B vaccine in healthy children. Hum Vaccin Immunother 2012; 8(8):1071-6; PMID:22854666; http://dx.doi.org/10.4161/hv.20656
   PubMed Web of Science ®Google Scholar
• Most J, Larcher C, Vogetseder W, Prodinger WM, Huemer HP, Ebenbichler CF, Dierich MP. Recombinant versus plasma-derived hepatitis B vaccine: comparison of immunogenicity in medical students. Vaccine 1992; 10(11):740-1; PMID: 1308114; http://dx.doi.org/10.1016/0264-410X(92)90507-G
   PubMed Web of Science ®Google Scholar
• Middleman AB. Hepatitis B immunization among adolescents. Curr Opin Pediatr 1995; 7(4):366-70; http://dx.doi.org/10.1097/00008480-199508000-00004
   PubMedGoogle Scholar
• Cui F, Drobeniuc J, Hadler SC, Hutin YJ, Ma F, Wiersma S, et al. Review of hepatitis B surveillance in China: Improving information to frame future directions in prevention and control. Vaccine 31S:J79-84, 2013; http://dx.doi.org/10.1016/j.vaccine.2013.05.054
   Google Scholar
• Fine PE. Herd immunity: history, theory, practice. Epidemiol Rev 1993; 15(2):265-302; PMID:8174658
   PubMed Web of Science ®Google Scholar
• Harpaz R, McMahon BJ, Margolis HS, Shapiro CN, Havron D, Carpenter G, Bulkow LR, Wainwright RB. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. J Infect Dis 2000; 181(2):413-8; PMID:10669320; http://dx.doi.org/10.1086/315259
   PubMed Web of Science ®Google Scholar
• Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet 2000; 355(9203):561-5; PMID:10683019; http://dx.doi.org/10.1016/S0140-6736(99)07239-6
   PubMed Web of Science ®Google Scholar
• Gunson RN, Shouval D, Roggendorf M, Zaaijer H, Nicholas H, Holzmann H, de Schryver A, Reynders D, Connell J, Gerlich WH, et al. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol 2003; 27(3):213-30; PMID:12878084; http://dx.doi.org/10.1016/S1386-6532(03)00087-8
   PubMed Web of Science ®Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Epidemiological serosurvey of Hepatitis B in China-Declining HBV prevalence due to Hepatitis B vaccination. Vaccine, 2009 27:6550-7; PMID:19729084; http://dx.doi.org/10.1016/j.vaccine.2009.08.048
   PubMed Web of Science ®Google Scholar